Molecular Markers Associated With the Response to Therapy With Everolimus in Patients With Renal Cell Carcinoma
Siberian Journal of Oncology - Russian Federation
doi 10.21294/1814-4861-2016-15-2-42-47
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Tomsk Cancer Research Institute